My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Agenda Package - 9-15-12 Reg. Meeting
public access
>
Clerk
>
AGENDA PACKAGES
>
2012
>
Agenda Package - 9-15-12 Reg. Meeting
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
12/11/2018 4:54:18 PM
Creation date
9/12/2012 8:17:19 AM
Metadata
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
147
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Attachment D L 2 {y <br /> Certifications Regarding, Drug-Free Work-Place; Lobbying; and <br /> Debarment, Suspension and Other Responsibility Matters <br /> 1. Drug-Free Work-Place <br /> The undersigned (authorized official)certifies that it will provide a drug-free workplace in accordance with the Drug- <br /> Free Work-Place Act of 1988, 45 CFR Part 76, subpart F. The certification set out below is a material representation <br /> of fact upon which reliance will be placed when awarding the grant. False certification or violation of the certification <br /> shall be grounds for suspension of payments, suspensions or termination of grants or government wide suspension or <br /> debarment. <br /> The grantee certifies that it will or will continue to provide a drug-free workplace by: <br /> (a) Publishing a statement notifying employees that the unlawful manufacture, distribution, dispensing, <br /> possession, or use of a controlled substance is prohibited in the grantee's workplace and specifying the <br /> actions that will be taken against employees for violation of such prohibition; <br /> (b) Establishing an on-going drug-free awareness program to inform employees about <br /> (1) The dangers of drug abuse in the workplace; <br /> (2)The grantee's policy of maintaining a drug-free workplace; <br /> (3) Any available drug counseling, rehabilitation, and employee assistance programs; and <br /> (4)The penalties that may be imposed upon employees for drug abuse violations occurring in the <br /> workplace; <br /> (c)Making it a requirement that each employee to be engaged in the perfonnance of the grant be given a copy <br /> of the statement required by paragraph (a); above; <br /> (d)Notifying the employee in the statement required by paragraph (a) that, as a condition of employment <br /> under the grant, the employee will— <br /> (1)Abide by the tenns of the statement; and <br /> (2)Notify the employer in writing of his or her conviction for a violation of a criminal drug statute <br /> occurring in the workplace no later than five calendar days after such conviction; <br /> (e) Notifying the agency, in writing, within 10 calendar days after receiving notice under subparagraph (d)(2), <br /> above, from an employee or otherwise receiving actual notice of such conviction. Employers of convicted <br /> employees must provide notice, including position title, to Agency on whose grant activity the convicted <br /> employee was working. <br /> Notices shall include the identification number(s) of each affected grant; <br /> (f) Taking one of the following actions, within 30 days of receiving notice under subparagraph (d)(2), above, <br /> with respect to any employee who is so convicted— <br /> (1) Taking appropriate personnel action against such an employee, up to and including termination, <br /> consistent with the requirements of the Rehabilitation Act of 1973, as amended; or <br /> (2) Requiring such employee to participate satisfactorily in a drug abuse assistance or rehabilitation <br /> program approved for such purposes by a Federal, State, or local health, law enforcement, or other <br /> appropriate agency; <br /> (g) Making a good faith effort to continue to maintain a drug-free workplace through implementation of <br /> paragraphs (a), (h), (c), (d), (e), and (f). <br /> The grantee certifies that, as a condition of the grant, it will not engage in the unlawful manufacture, distribution, <br /> dispensing, possession or use of a controlled substance in conducting any activity with the grant. <br /> Page 13 of 15 <br />
The URL can be used to link to this page
Your browser does not support the video tag.